Advertisement
Research Article

Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice

  • Hayat Caidi,

    Affiliation: National Center for Immunization and Respiratory Diseases, Division of Viral Diseases, Gastroenteritis and Respiratory Viruses Laboratory Branch, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, United States of America

    X
  • Jennifer L. Harcourt,

    Affiliation: National Center for Immunization and Respiratory Diseases, Division of Viral Diseases, Gastroenteritis and Respiratory Viruses Laboratory Branch, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, United States of America

    X
  • Ralph A. Tripp,

    Affiliation: College of Veterinary Medicine, Department of Infectious Diseases, University of Georgia, Athens, Georgia, United States of America

    X
  • Larry J. Anderson,

    Affiliation: Division of Pediatric Infectious Diseases, Emory Children’s Center, Atlanta, Georgia, United States of America

    X
  • Lia M. Haynes mail

    loh5@cdc.gov

    Affiliation: National Center for Immunization and Respiratory Diseases, Division of Viral Diseases, Gastroenteritis and Respiratory Viruses Laboratory Branch, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, United States of America

    X
  • Published: December 27, 2012
  • DOI: 10.1371/journal.pone.0051485

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.